R
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K494.3 KBRegulus Therapeutics Inc.Jun 25, 9:12 AM ET·0001104659-25-062408
- 10-Q5.5 MBRegulus Therapeutics Inc.May 8, 4:38 PM ET·0001628280-25-023872
- 8-K202.5 KBRegulus Therapeutics Inc.May 8, 4:15 PM ET·0001193125-25-115978
- 10-K/A894.2 KBRegulus Therapeutics Inc.Apr 30, 4:05 PM ET·0001193125-25-107128
- 8-K1.1 MBRegulus Therapeutics Inc.Apr 30, 8:27 AM ET·0001193125-25-105845
- 8-K1.5 MBRegulus Therapeutics Inc.Mar 27, 7:15 AM ET·0001193125-25-064685
- 10-K8.3 MBRegulus Therapeutics Inc.Mar 13, 4:30 PM ET·0001628280-25-012627
- 8-K201.9 KBRegulus Therapeutics Inc.Mar 13, 4:15 PM ET·0001193125-25-053925
- 8-K198.3 KBRegulus Therapeutics Inc.Mar 4, 4:01 PM ET·0001193125-25-045567
- SC 13G/A77.3 KBRegulus Therapeutics Inc.Nov 14, 5:46 PM ET·0001104659-24-119293
Insiders
10- ALNYLAM PHARMACEUTICALS, INC.10% Owner
- ASTRAZENECA AB10% Owner
- ASTRAZENECA PLC10% Owner
- Aker Christopher RaySr. VP & General Counsel
- BALTIMORE DAVIDDirector
- BARRIS PETER J10% Owner
- BASKETT FOREST10% Owner
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
Tickers
No tickers on record
Addresses
business
4224 CAMPUS POINT COURT SUITE 210
SAN DIEGO, CA, 92121
mailing
4224 CAMPUS POINT COURT SUITE 210
SAN DIEGO, CA, 92121